ReviewMedical oncology (Northwood, London, England)2022
Therapeutic landscape of advanced HER2-positive breast cancer in 2022.
Ruby Gupta et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled itcites it
ReviewMedical oncology (Northwood, London, England)2022
Ruby Gupta et al.PubMed ↗Publisher ↗
No numbers read from the abstract.